Sawicka-Grzelak A, Rokosz A, Luczak M
Zakład Mikrobiologii Lekarskiej AM w Warszawie.
Med Dosw Mikrobiol. 1999;51(3-4):239-47.
The aim of this study was to evaluate the drug susceptibility of 100 Enterococcus spp. strains isolated from patients hospitalized in State Clinical Hospital No 1 in Warsaw. All strains were identified (API 20 STREP) and their susceptibility to antibiotics was tested (ATB STREP) in automatic ATB system. Additionally, PYRase activity, beta-lactamase production (in nitrocefin test), MICs for vancomycin and teicoplanin (E test), HLAR--high level aminoglycoside resistance and susceptibility to vancomycin, teicoplanin, piperacillin and piperacillin/tazobactam (disc diffusion method) were determined. E. faecalis ATCC 29212 was used as the control strain. Fifty E. faecalis, 45 E. faecium, 2 E. casseliflavus, 2 E. durans and 1 E. avium strain were cultured. All strains were PYRase-positive and beta-lactamase-negative. Ten isolates demonstrated intermediate susceptibility to vancomycin (6--E. faecalis and 4--E. faecium). One E. faecalis strain was intermediately susceptible to both glycopeptides. One E. casseliflavus strain showed low-level resistance to vancomycin, but this strain was susceptible to teicoplanin--phenotype Van C. HLAR strains were found among 31 E. faecalis and 40 E. faecium strains. 48 E. faecalis strains were susceptible to piperacillin and 49 to piperacillin/tazobactam. Whereas, 41 E. faecium were resistant to both these drugs. Thirty six per cent of isolates were resistant to penicillin and ampicillin, 73% to erythromycin, 87% to tetracycline, 89% to lincomycin and 56% to nitrofurantoin. Some discrepancies were noticed between the results of different methods applied for susceptibility testing--ATB system, E test and disc diffusion. These discrepancies concerned HLAR detection and susceptibility to glycopeptides determination. The best methods were: disc-diffusion for HLAR detection and E test for determination of resistance to vancomycin and teicoplanin. Increasing resistance to antimicrobial agents is observed in clinical Enterococcus spp. isolates cultured in our laboratory, especially in E. faecium strains. It is necessary to control the dissemination of multiresistant Enterococcus spp. strains in hospital wards.
本研究旨在评估从华沙第一国立临床医院住院患者中分离出的100株肠球菌属菌株的药敏性。所有菌株均通过API 20 STREP进行鉴定,并在自动ATB系统中检测其对抗生素的敏感性(ATB STREP)。此外,还测定了PYR酶活性、β-内酰胺酶产生情况(硝基头孢菌素试验)、万古霉素和替考拉宁的最低抑菌浓度(E试验)、高水平氨基糖苷类耐药性(HLAR)以及对万古霉素、替考拉宁、哌拉西林和哌拉西林/他唑巴坦的敏感性(纸片扩散法)。粪肠球菌ATCC 29212用作对照菌株。共培养了50株粪肠球菌、45株屎肠球菌、2株格氏肠球菌、2株耐久肠球菌和1株鸟肠球菌。所有菌株PYR酶均呈阳性,β-内酰胺酶均呈阴性。10株分离株对万古霉素表现出中介敏感性(6株粪肠球菌和4株屎肠球菌)。1株粪肠球菌菌株对两种糖肽类药物均呈中介敏感性。1株格氏肠球菌菌株对万古霉素表现出低水平耐药,但对替考拉宁敏感——Van C表型。在31株粪肠球菌和40株屎肠球菌菌株中发现了HLAR菌株。48株粪肠球菌菌株对哌拉西林敏感,49株对哌拉西林/他唑巴坦敏感。而41株屎肠球菌对这两种药物均耐药。36%的分离株对青霉素和氨苄西林耐药,73%对红霉素耐药,87%对四环素耐药,89%对林可霉素耐药,56%对呋喃妥因耐药。在药敏试验的不同方法(ATB系统、E试验和纸片扩散法)结果之间发现了一些差异。这些差异涉及HLAR检测和对糖肽类药物敏感性的测定。最佳方法为:纸片扩散法用于HLAR检测,E试验用于测定对万古霉素和替考拉宁的耐药性。在我们实验室培养的临床肠球菌属分离株中观察到对抗菌药物的耐药性不断增加,尤其是在屎肠球菌菌株中。有必要控制多重耐药肠球菌属菌株在医院病房中的传播。